The Functions and Phenotypes of Microglia in Alzheimer's Disease

Risako Fujikawa1, Makoto Tsuda1,2

  • 1Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Cells
|May 16, 2023
PubMed

Insights

Microglia, the brain's immune cells, play a crucial role in Alzheimer's disease (AD) pathology. Understanding their diverse states and functions is key to developing new AD therapies.

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Alzheimer's disease (AD) is a leading cause of neurodegeneration globally, with limited therapeutic success.
  • Microglia, the resident immune cells of the central nervous system, are increasingly recognized for their importance in AD.
  • Recent advancements reveal diverse microglial cell states within AD.

Purpose of the Study:

  • To systematically review microglial responses to key AD pathologies (amyloid-β and tau tangles).
  • To examine microglial risk factor gene expression in AD.
  • To discuss protective microglial phenotypes and their link to AD-associated inflammation and chronic pain.

Main Methods:

  • Systematic review of scientific literature on microglia in Alzheimer's disease.
  • Analysis of single-cell RNA sequencing data to identify heterogeneous microglial states.
  • Integration of findings on amyloid-β, tau pathology, risk genes, and inflammation.

Main Results:

  • Microglia exhibit heterogeneous responses to amyloid-β plaques and tau tangles.
  • Specific risk factor genes are expressed by microglia in AD.
  • Protective microglial states and their connection to inflammation in AD and chronic pain are identified.

Conclusions:

  • Microglial heterogeneity is central to Alzheimer's disease pathogenesis.
  • Targeting specific microglial states offers potential therapeutic avenues for AD.
  • Further understanding of microglia-immune interactions is crucial for novel AD treatment strategies.